Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.91M Buy
162,515
+3,656
+2% +$95.6K 0.1% 162
2026
Q1
$4.46M Sell
158,859
-19,046
-11% -$507K 0.12% 141
2025
Q4
$4.43M Sell
177,905
-28,166
-14% -$710K 0.12% 142
2025
Q3
$5.25M Sell
206,071
-8,167
-4% -$202K 0.15% 123
2025
Q2
$5.19M Buy
214,238
+20,474
+11% +$477K 0.15% 120
2025
Q1
$4.91M Sell
193,764
-5,898
-3% -$154K 0.17% 113
2024
Q4
$5.3M Sell
199,662
-49,599
-20% -$1.35M 0.18% 109
2024
Q3
$7.21M Sell
249,261
-2,684
-1% -$78.3K 0.24% 95
2024
Q2
$7.05M Buy
251,945
+2,265
+0.9% +$62.4K 0.26% 89
2024
Q1
$6.93M Buy
249,680
+53,190
+27% +$1.48M 0.26% 89
2023
Q4
$5.66M Sell
196,490
-68,625
-26% -$2.07M 0.32% 84
2023
Q3
$8.79M Sell
265,115
-10,686
-4% -$378K 0.38% 67
2023
Q2
$10.1M Buy
275,801
+8,631
+3% +$336K 0.43% 63
2023
Q1
$10.9M Sell
267,170
-821
-0.3% -$35.5K 0.47% 57
2022
Q4
$13.7M Buy
267,991
+58,967
+28% +$2.83M 0.61% 44
2022
Q3
$9.15M Sell
209,024
-86,287
-29% -$4.19M 0.62% 46
2022
Q2
$15.5M Sell
295,311
-845
-0.3% -$43.1K 0.68% 32
2022
Q1
$15.3M Sell
296,156
-2,462
-0.8% -$128K 0.58% 40
2021
Q4
$17.6M Sell
298,618
-20,227
-6% -$1M 0.64% 37
2021
Q3
$13.7M Sell
318,845
-2,873
-0.9% -$127K 0.53% 55
2021
Q2
$12.6M Sell
321,718
-5,142
-2% -$200K 0.47% 60
2021
Q1
$11.8M Buy
+326,860
New +$11.6M 0.47% 58
2020
Q3
$12.2M Buy
351,069
+622
+0.2% +$21.8K 0.57% 51
2020
Q2
$10.9M Sell
350,447
-7,632
-2% -$259K 0.54% 51
2020
Q1
$11.1M Sell
358,079
-1,354
-0.4% -$46.1K 0.64% 45
2019
Q4
$13.4M Buy
359,433
+475
+0.1% +$16.9K 0.61% 47
2019
Q3
$12.2M Sell
358,958
-5,322
-1% -$194K 0.61% 48
2019
Q2
$15M Sell
364,280
-2,221
-0.6% -$88.2K 0.73% 43
2019
Q1
$14.8M Buy
366,501
+10,191
+3% +$408K 0.74% 40
2018
Q4
$14.8M Sell
356,310
-1,046
-0.3% -$43.4K 0.88% 32
2018
Q3
$14.9M Sell
357,356
-3,457
-1% -$133K 0.74% 36
2018
Q2
$12.4M Sell
360,813
-18,678
-5% -$638K 0.64% 44
2018
Q1
$12.8M Buy
379,491
+57,818
+18% +$1.99M 0.65% 44
2017
Q4
$11.1M Sell
321,673
-65,625
-17% -$2.24M 0.75% 34
2017
Q3
$13.1M Sell
387,298
-474
-0.1% -$15.2K 0.68% 43
2017
Q2
$12.4M Sell
387,772
-2,000
-0.5% -$63.1K 0.67% 45
2017
Q1
$12.7M Sell
389,772
-14,584
-4% -$460K 0.7% 39
2016
Q4
$12.5M Sell
404,356
-75,013
-16% -$2.29M 0.71% 40
2016
Q3
$15.4M Buy
479,369
+34,088
+8% +$1.14M 0.91% 28
2016
Q2
$14.9M Buy
445,281
+55,243
+14% +$1.76M 0.89% 30
2016
Q1
$11M Buy
390,038
+40,531
+12% +$1.16M 0.65% 47
2015
Q4
$10.7M Sell
349,507
-1,238
-0.4% -$38.9K 0.63% 49
2015
Q3
$10.5M Buy
350,745
+8,682
+3% +$278K 0.63% 46
2015
Q2
$10.9M Sell
342,063
-13,647
-4% -$445K 0.61% 53
2015
Q1
$11.7M Buy
355,710
+124
+0% +$3.94K 0.65% 47
2014
Q4
$10.5M Buy
355,586
+20,785
+6% +$596K 0.57% 51
2014
Q3
$9.39M Sell
334,801
-1,666
-0.5% -$46.8K 0.53% 57
2014
Q2
$9.47M Sell
336,467
-6,759
-2% -$193K 0.53% 58
2014
Q1
$10.5M Sell
343,226
-22,690
-6% -$677K 0.6% 51
2013
Q4
$10.6M Sell
365,916
-9,450
-3% -$275K 0.61% 47
2013
Q3
$10.2M Sell
375,366
-4,692
-1% -$128K 0.63% 42
2013
Q2
$10.1M Buy
+380,058
New +$10.5M 0.66% 42

Other funds holding PFE

WesBanco Bank's PFE Position: Q2 2026 in Review

WesBanco Bank increased its Pfizer (PFE) stake by 2.3% in Q2 2026, buying an estimated $95.6K and bringing the position to 162,515 shares worth $3.91M. The position accounts for 0.1% of the portfolio, ranked #162.

WesBanco Bank first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.6M in Q4 2021. 1,334 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • WesBanco Bank held 162,515 shares of Pfizer worth $3.91M as of Q2 2026.
  • WesBanco Bank bought 3,656 Pfizer shares in Q2 2026, an estimated $95.6K.
  • Pfizer made up 0.1% of WesBanco Bank's portfolio in Q2 2026, its #162 holding.
  • WesBanco Bank first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • WesBanco Bank's Pfizer position peaked at $17.6M in Q4 2021.
  • 1,334 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.